{"input_url":"https://www.syneoshealth.com/insights-hub/ai-accountability-how-small-biopharma-can-scale-smarter","gnews_decode":"https://www.syneoshealth.com/insights-hub/ai-accountability-how-small-biopharma-can-scale-smarter","http_status":200,"final_url":"https://www.syneoshealth.com/insights-hub/ai-accountability-how-small-biopharma-can-scale-smarter","html_length":128829,"trafilatura_result":"ok","text_length":1813,"text_preview":"AI With Accountability: How Small Biopharma Can Scale Smarter\nIn this episode, recorded on the ground at Asembia's AXS26 Summit, host Chris Van Denburg sits down with George Jones, Chief Commercial Officer at Biofrontera, to explore how artificial intelligence (AI) is helping smaller biopharmaceutic","verdict":"OK"}